Two recently postulated risk factors for the expression of Alzheimer's disease (AD) include: a) enhanced HPA axis activity in normal aging, and b) the presence of the apolipoprotein-E (apoE) epsilon4 allele. Studies in the rodent suggest that aging enhances hypothalamic-pituitary- adrenocortical (HPA) axis responsivity and that the resultant increase in glucocorticoid (GC) secretion lowers the threshold for aging-associated hippocampal neuronal damage and cognitive decline. The relevance to old humans of the provocative findings in old rodents has not been explored. Studies in late onset familial AD suggest that the presence of an isoform of apoE, epsilon4, lowers the age of expression of dementia in these families. Furthermore, epidemiologic studies demonstrate a significantly although variably higher frequency of the epsilon4 allele in sporadic late onset AD than in normal older persons. To explore HPA axis activity and apoE genotype as risk factors for cognitive decline in older humans, we propose the following Specific Aims: 1) To address the hypothesis that high HPA axis activity and/or presence of the apoE-epsilon allele increases cognitive decline in older humans, we will measure longitudinally the effects of HPA activity as estimated by urinary and salivary cortisol measurements on cognitive function within two groups of older subjects at high risk for cognitive decline: very elderly (over age 80) nondemented subjects and patients with AD. In addition, all subjects will be genotyped for apoE alleles. 2) To address the hypothesis that mechanism for enhanced HPA axis activity in older humans (as in older rats) is decreased sensitivity of the HPA axis to GC feedback inhibition, we will compare sensitivity of the HPA axis to GC feedback inhibition among nondemented very old persons, normal young persons, and patients with AD. If elevated circulating GC levels contribute to hippocampal neuronal degeneration in the nonhuman primate, and if enhanced HPA axis responsivity and/or the presence of the apoE- epsilon4 allele in human aging and AD is associated with increased cognitive decline, such findings would be relevant to designing treatment strategies to delay the onset or slow the progression of Alzheimer's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005136-16S1
Application #
6216960
Study Section
Project Start
1999-08-15
Project End
2000-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Moreno, Monica A; Or-Geva, Noga; Aftab, Blake T et al. (2018) Molecular signature of Epstein-Barr virus infection in MS brain lesions. Neurol Neuroimmunol Neuroinflamm 5:e466
Wang, Lucy Y; Raskind, Murray A; Wilkinson, Charles W et al. (2018) Associations between CSF cortisol and CSF norepinephrine in cognitively normal controls and patients with amnestic MCI and AD dementia. Int J Geriatr Psychiatry 33:763-768
Condello, Carlo; Lemmin, Thomas; Stöhr, Jan et al. (2018) Structural heterogeneity and intersubject variability of A? in familial and sporadic Alzheimer's disease. Proc Natl Acad Sci U S A 115:E782-E791
Blue, E E; Yu, C-E; Thornton, T A et al. (2018) Variants regulating ZBTB4 are associated with age-at-onset of Alzheimer's disease. Genes Brain Behav 17:e12429
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Goins, R Turner; Schure, Mark; Jensen, Paul N et al. (2018) Lower body functioning and correlates among older American Indians: The Cerebrovascular Disease and Its Consequences in American Indians Study. BMC Geriatr 18:6
Iverson, Grant L; Keene, C Dirk; Perry, George et al. (2018) The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features. J Alzheimers Dis 61:17-28
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Flanagan, Margaret E; Keene, Christopher Dirk; Louis, David N et al. (2018) Localized crystal-storing histiocytosis of the posterior fossa. Neuropathology 38:529-534

Showing the most recent 10 out of 753 publications